CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Practice and Policy

ONCOLOGY. Vol. 25 No. 1
PRACTICE & POLICY 

Implementing EHRs in Community Oncology Practices

By Cary A. Presant, MD, FACP1, Linda Bosserman, MD, FACP1,
Wendy McNatt1, Brandon Emilio1 | January 19, 2011
1 Wilshire Oncology Medical Group, La Verne, California

By their very nature, electronic health records (EHRs) facilitate appropriate documentation and make it possible to read and understand submitted records in terms of their appropriate comprehensive nature. Other potential EHR benefits include the ability to enhance communication, measure and improve the quality of care, increase clinical trial participation, mine data, participate in e-prescribing, and improve billing processes.

Improving Communication
To provide quality healthcare, communication is vital. Using an EHR, physicians can more easily communicate regarding current and past medical conditions with other providers in their practice, with referring or co-managing physicians, and with patients themselves. This technology also enhances communication across many providers and service locations—in both the practice and hospital setting.

Improving Quality of Care
Within a practice, physicians may use different treatment strategies or follow different decision-making processes. EHRs can facilitate provision of consistent quality within a practice and help to ensure consistency of therapeutic approaches by different physicians.

EHRs allow practices to produce data-driven reports on patients by diagnosis, stage, and tumor features, with delivered care, outcomes, toxicities, warranted variations, and cost. Putting these data to use, practices can show the value and quality of care delivered while improving efficiencies and safety and facilitating the use of evidence-based guidelines. In fact, EHRs facilitate the delivery of quality care, making it possible to compare an individual patient’s therapy with guidelines established by the practice, or with guidelines established by other entities, such as ASCO, NCCN, payers, or other organizations. EHRs also enhance a practice’s ability to participate in national programs such as:

• ASCO's Quality Oncology Practice Initiative (QOPI).
• Medicare's Physician Quality Reporting Initiative (PQRI).
• Physician- and physician network–driven comprehensive oncology initiatives, including several oncology medical home pilots, US Oncology’s Innovent program, and University of Pittsburgh’s Via program.
• Payer-led quality of care projects.

Improving Research Programs
Oncology-specific EHRs have fields for multimodality care, including surgery and radiation therapy, complete therapy information, and length of course of treatment, which are required for central registry. EHRs make it easier for practices to conduct data projects to understand the nature of the following in their patients:

• Cancer and comorbid diseases.
• Medications.
• General health or performance status.
• Delivered therapies, including multimodality, prevention, recovery, support, and hospice therapies.

These data, in turn, allow the practice to perform an analysis of value, relating quality (delivered care and outcome) to defined delivery costs.

Physicians should consider every patient for possible inclusion in a clinical trial, and EHRs can help physicians review patients for eligibility. The technology can also help practices restrict opening new trials to those types of patients most commonly seen by physicians in that practice.

Improving Billing and Coding
Standardized data elements in an EHR make it easier to document complex clinic work; this documentation in turn supports appropriate high-level billing codes. As payment systems move toward payments for cognitive services, complex care coordination, and oversight and outcomes, the use of an oncology-specific EHR becomes essential. At the same time, the value of EHRs to payers is also becoming clearer. As oncology costs become the number one cost to payers, both payers and providers are recognizing that the ability to analyze and report on the complexity, cost, and outcomes of delivered care will significantly aid physicians and medical groups.

E-Prescribing
Electronic prescribing is gradually being required, and various insurers, including Medicare, have incentive payment programs for e-prescribers. E-prescribing reduces mistakes and facilitates evaluation of the growing list of potential drug interactions. Again, by their very nature, EHRs facilitate e-prescribing.

Challenges Associated with EHRs
At this point, many practices understand the challenges related to EHR implementation. The first challenge is, of course, how to pay for the technology. EHRs entail not only costs for hardware, but also for software and ongoing software needs, hardware and infrastructure maintenance, and training. Staff must be trained and re-trained as systems are updated, and practices will need to hire or contract with an information technology (IT) coordinator and/or IT networking expert. A second challenge is that all members of the practice staff must “buy in” to the need for and benefits of this technology. Moving to an EHR requires time and effort on the part of all staff members. A final challenge is the ongoing commitment required by EHRs. In addition to the initial hardware and software purchases, EHRs require additional programming, maintenance, and development of interfaces.

The Implementation Process
Selecting, purchasing, and implementing an EHR is a complex and time-consuming process, and the practice will need to organize an EHR leadership team that will help each group review all options in the EHR and decide how to standardize each person’s use of the EHR.

Step 1: Product decision
Several competing oncology-specific EHRs are available, as are larger systems that are often hospital-based and that may or may not have oncology modules you can build or buy. When choosing an EHR, keep in mind the importance of being able to generate reports. Another crucial factor in EHR selection is vendor support. We recommend site visits and discussions with EHR-savvy practices before making this crucial decision. For example, ASCO offers a social networking website—Oncology EHR: Quality and Safety—where oncologists can share information about the use of EHRs: http://ehr.ascoexchange.org.

Step 2: Needs assessment
Once an EHR is selected, the next step is to decide how much programming is needed or whether clinical and/or EHR-user networks or other experienced colleagues will let you purchase or copy their programs and methodologies to get you started. If your practice has to program the EHR itself, it can take months to pull staff together to standardize all the chemotherapy regimens with appropriate support regimens and educational input for programming—and all of this must be done before you can implement the EHR in the clinic. You will also need to decide on formats for notes and procedures and therapy administrations, and agree on what data are vital to collect at various types of office visits.

Step 3: Data storage and ownership.
The server on which the data are stored may be hosted by either the vendor or a third-party entity, or it may be located within the practice. Regardless of where the data reside, back-ups are critical. Data ownership is another key consideration. Owning your data is important; however, some EHR vendors reduce the purchase price or maintenance fees in exchange for being able to “sell” your de-identified (HIPAA-compliant) data. Owning your data can be a source of practice revenue if you partner with networks to enhance the details and value of those data. If an EHR vendor owns the server and the de-identified data, it can control when and whether the data are sold. If the practice owns the server and the de-identified data, it can decide when to sell the data—either alone or within a clinical and/or EHR-user network. The ability to report on your care and benchmark with other programs is another key reason to maintain control of your data.

Step 4: Training prior to implementation
Setting aside time for training either off-site or during non-clinical-care time is critical to allow the team to focus on learning the new system.

Going Live
The practice must decide on the most practical method for EHR implementation. Having staff pre-populate demographic information and as much of the previous medical record as possible can be a significant help. This information might include diagnoses, cancer staging and tumor features, previous therapies, medications, allergies, and social, family, and medical history. Practice leaders will need to decide whether to go live with everyone at once or in phases—rolling out EHR use by staffing groups. Multi-site practices need to consider whether to go live across all sites at once, only with certain staff in all clinics, or to roll out implementation site by site. Another important implementation decision is whether to go paperless immediately or continue to use the paper chart for part of the record until more interfaces (with laboratory, pathology, or radiology, for example)can be created or afforded.

Moving from the “story” to mineable data elements
An often unrecognized issue in transitioning to EHRs is the fact that clinicians are trained to capture the patient story (the medical history). In the complex world of cancer care, the key information is not in the story, but in the clickable, mineable data that we need in order to demonstrate the complexity of diagnostic, therapeutic, and care needs for cancer patients. While this transition might be challenging for some clinicians, capturing these data in the EHR allows any provider to review a patient chart and rapidly capture the complete 'story' of that patient, and allows for appropriate care by alternate providers or care team members.

Ongoing needs
After implementation, your EHR vendor should provide ongoing support, upgrades, and training. With EHR adoption, all members of the team will be asked to practice a bit differently. This change can be stressful for the first several months or more, and some practitioners may need additional support. Plan for regularly scheduled supervisory meetings to review the implementation process, address any problems or additional programming needs, and share best practices.

In the end, your practice must understand that electronic health records are here to stay. Initially EHR adoption can be challenging, but ultimately EHRs will help oncology practices improve the quality of their care delivery and their documentation for prompt payment and mandated public reporting. EHR use in oncology practices will allow them to demonstrate the known—but previously hard to prove—value of community, as well as academic, oncology care, thus enhancing professional satisfaction and pride in a demanding career.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Alan Slomowitz | January 23, 2011 10:49 PM EST

Not very helpful. Oncology specific EMRs are only a few in number. Many will say they have one but really do not. The radiation therapy based ones by the accelertor companies are nearly useless for medical oncology and are very weak otherwise. The only big thing about them is the price. Integration of the non-accelerator based ones for scheduling and charge capture are really not available or made difficult due to proprietary interfaces.

A spreadsheet with the oncology specific ones would be helpful.

 






 
RELATED CONTENT

Preventing Burnout in Oncology
June 18, 2013
Supreme Court Ruling Invalidates Myriad’s BRCA Gene Patents
June 14, 2013
How the Sequester Cuts Are Harming Oncology
ONCOLOGY,  May 15, 2013
Are CML Drugs Priced Out of Reach?
May 2, 2013
US Cancer Organizations Say Medicare Cuts Will Negatively Impact Cancer Patients
April 29, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter


CancerNetwork on Facebook
 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Health Care
Evidence on Health Care
Guidelines on Health Care
Patient Education on Health Care
Clinical Trials on Health Care
Practical Articles on Health Care
Research and Reviews on Health Care
All "Health Care" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy